DECT vs. XUSP

Last updated Jun 4, 2026

DECT (Allianzim U.S. Large Cap Buffer10 Dec ETF) and XUSP (Innovator Uncapped Accelerated U.S. Equity ETF) are both Options Trading funds. Both are actively managed. Over the past 3 years, DECT returned 14.52%/yr vs 25.24%/yr for XUSP. With a 0.95 correlation, they move nearly in lockstep. DECT charges 0.74%/yr vs 0.79%/yr for XUSP.

Performance

DECT vs. XUSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Allianzim U.S. Large Cap Buffer10 Dec ETF (DECT) and Innovator Uncapped Accelerated U.S. Equity ETF (XUSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DECT achieves a 7.16% return, which is significantly lower than XUSP's 12.67% return.

DECT

• 1D: -0.28%
• 1M: 3.06%
• YTD: 7.16%
• 6M: 7.61%
• 1Y: 21.15%
• 3Y*: 14.52%
• 5Y*: —
• 10Y*: —

XUSP

• 1D: -0.86%
• 1M: 7.03%
• YTD: 12.67%
• 6M: 12.12%
• 1Y: 33.74%
• 3Y*: 25.24%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DECT vs. XUSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
DECT Allianzim U.S. Large Cap Buffer10 Dec ETF	7.16%	15.04%	11.86%	19.35%	-4.33%
XUSP Innovator Uncapped Accelerated U.S. Equity ETF	12.67%	18.27%	30.60%	26.46%	-6.40%

Correlation

The correlation between DECT and XUSP is 0.97 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.97
Correlation (3Y) Calculated over the trailing 3-year period	0.95
Correlation (All Time) Calculated using the full available price history since Dec 2, 2022	0.95

The correlation between DECT and XUSP has been stable across timeframes, ranging from 0.95 to 0.97 - a consistent structural relationship.

DECT vs. XUSP - Sectors Allocation Comparison

Sectors	DECT	XUSP
Technology	36.2%	36.2%
Financial Services	11.9%	11.9%
Communication Services	10.9%	10.9%
Consumer Cyclical	10.1%	10.1%
Healthcare	8.4%	8.4%
Industrials	8.1%	8.1%
Consumer Defensive	4.9%	4.9%
Energy	3.5%	3.5%
Utilities	2.3%	2.3%
Real Estate	1.9%	1.9%
Basic Materials	1.8%	1.8%

Return for Risk

DECT vs. XUSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DECT

DECT Risk / Return Rank: 78
DECT Sharpe Ratio Rank: 76
DECT Sortino Ratio Rank: 78
DECT Omega Ratio Rank: 81
DECT Calmar Ratio Rank: 70
DECT Martin Ratio Rank: 83

XUSP

XUSP Risk / Return Rank: 62
XUSP Sharpe Ratio Rank: 64
XUSP Sortino Ratio Rank: 61
XUSP Omega Ratio Rank: 61
XUSP Calmar Ratio Rank: 57
XUSP Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DECT vs. XUSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Allianzim U.S. Large Cap Buffer10 Dec ETF (DECT) and Innovator Uncapped Accelerated U.S. Equity ETF (XUSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DECT	XUSP	Difference
Sharpe ratio: Return per unit of total volatility	2.45	2.13	+0.32
Sortino ratio: Return per unit of downside risk	3.48	2.87	+0.61
Omega ratio: Gain probability vs. loss probability	1.48	1.37	+0.11
Calmar ratio: Return relative to maximum drawdown	3.48	2.80	+0.68
Martin ratio: Return relative to average drawdown	16.66	11.82	+4.84
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DECT vs. XUSP - Sharpe Ratio Comparison

The current DECT Sharpe Ratio is 2.45, which is comparable to the XUSP Sharpe Ratio of 2.13. The chart below compares the historical Sharpe Ratios of DECT and XUSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DECT	XUSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.45	2.13	+0.32
Sharpe Ratio (All Time) Calculated using the full available price history	1.36	1.04	+0.32

Drawdowns

DECT vs. XUSP - Drawdown Comparison

The maximum DECT drawdown since its inception was -13.26%, smaller than the maximum XUSP drawdown of -22.59%. Use the drawdown chart below to compare losses from any high point for DECT and XUSP.

Drawdown Indicators

	DECT	XUSP	Difference
Max Drawdown Largest peak-to-trough decline	-13.26%	-22.59%	+9.33%
Max Drawdown (1Y) Largest decline over 1 year	-6.11%	-12.13%	+6.02%
Max Drawdown (3Y) Largest decline over 3 years	-13.26%	-22.59%	+9.33%
Current Drawdown Current decline from peak	-0.28%	-0.86%	+0.58%
Average Drawdown Average peak-to-trough decline	-1.42%	-4.42%	+3.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.27%	2.86%	-1.59%

Volatility

DECT vs. XUSP - Volatility Comparison

The current volatility for Allianzim U.S. Large Cap Buffer10 Dec ETF (DECT) is 1.65%, while Innovator Uncapped Accelerated U.S. Equity ETF (XUSP) has a volatility of 4.13%. This indicates that DECT experiences smaller price fluctuations and is considered to be less risky than XUSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DECT	XUSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.65%	4.13%	-2.48%
Volatility (6M) Calculated over the trailing 6-month period	6.34%	11.89%	-5.55%
Volatility (1Y) Calculated over the trailing 1-year period	8.68%	15.90%	-7.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	10.23%	19.21%	-8.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	10.23%	19.21%	-8.98%

DECT vs. XUSP - Expense Ratio Comparison

DECT has a 0.74% expense ratio, which is lower than XUSP's 0.79% expense ratio.

Dividends

DECT vs. XUSP - Dividend Comparison

Neither DECT nor XUSP has paid dividends to shareholders.

Position	TTM	2025	2024
DECT Allianzim U.S. Large Cap Buffer10 Dec ETF	0.00%	0.00%	0.43%
XUSP Innovator Uncapped Accelerated U.S. Equity ETF	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both DECT and XUSP in my portfolio?

With a correlation of 0.97, DECT and XUSP move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, DECT or XUSP?

XUSP has higher volatility (4.13%) compared to DECT (1.65%). In terms of maximum drawdown, DECT dropped -13.26% vs XUSP's -22.59%.

Which ETF is better, DECT or XUSP?

On 3-year performance, XUSP leads with 25.24% vs 14.52% for DECT. On fees, DECT is cheaper at 0.74% per year. On volatility, DECT has been the lower-risk option at 1.65%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, DECT or XUSP?

Over the 3-year period, XUSP has performed better with a 25.24% return vs 14.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, DECT or XUSP?

DECT is cheaper with a 0.74% expense ratio, compared with 0.79% for XUSP.

Which ETF pays a higher dividend yield, DECT or XUSP?

DECT and XUSP have nearly identical dividend yields, around 0.00%.

What is the main difference between DECT and XUSP?

They also come from different issuers: Allianz and Innovator. Their fees differ too: 0.74% for DECT and 0.79% for XUSP.

Which has better risk-adjusted returns?

DECT currently has the higher Sharpe Ratio (2.45 vs 2.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.